Hossain Md Shamim, Abe Yuichi, Ali Fatma, Youssef Mohammed, Honsho Masanori, Fujiki Yukio, Katafuchi Toshihiko
Department of Neuroinflammation and Brain Fatigue Science.
Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
J Neurosci. 2017 Apr 12;37(15):4074-4092. doi: 10.1523/JNEUROSCI.3941-15.2017. Epub 2017 Mar 14.
Neuroinflammation characterized by activation of glial cells is observed in various neurodegenerative diseases including Alzheimer's disease (AD). Although the reduction of ether-type glycerophospholipids, plasmalogens (Pls), in the brain is reported in AD patients, the mechanism of the reduction and its impact on neuroinflammation remained elusive. In the present study, we found for the first time that various inflammatory stimuli reduced Pls levels in murine glial cells via NF-κB activation, which then downregulated a Pls-synthesizing enzyme, glycerone phosphate O-acyltransferase (Gnpat) through increased c-Myc recruitment onto the promoter. We also found that systemic injection of lipopolysaccharide, aging, and chronic restraint stress reduced brain Pls contents that were associated with glial NF-κB activation, an increase in c-Myc expression, and downregulation of in the mouse cortex and hippocampus. More interestingly, the reduction of Pls contents in the murine cortex itself could increase the activated phenotype of microglial cells and the expression of proinflammatory cytokines, suggesting further acceleration of neuroinflammation by reduction of brain Pls. A similar mechanism of reduction was also found in human cell lines, triple-transgenic AD mouse brain, and postmortem human AD brain tissues. These findings suggest a novel mechanism of neuroinflammation that may explain prolonged progression of AD and help us to explore preventive and therapeutic strategies to treat neurodegenerative diseases. Ether-type glycerophospholipids, plasmalogens (Pls), are reduced in the brain of Alzheimer disease (AD) patients. We found that inflammatory stimuli reduced Pls contents by downregulation of the Pls-synthesizing enzyme glycerone phosphate O-acyltransferase (Gnpat) through NF-κB-mediated recruitment of c-Myc onto the promoter in both murine and human cell lines. Murine brains after systemic lipopolysaccharide, chronic stress, and aging, as well as triple-transgenic AD mice and postmortem human AD brain tissues all showed increased c-Myc and reduced expression. Interestingly, knockdown of itself activated NF-κB in glial cell lines and microglia in mouse cortex. Our findings provide a new insight into the mechanism of neuroinflammation and may help to develop a novel therapeutic approach for neurodegenerative diseases such as AD.
在包括阿尔茨海默病(AD)在内的各种神经退行性疾病中,均可观察到以胶质细胞激活为特征的神经炎症。尽管有报道称AD患者大脑中醚型甘油磷脂——缩醛磷脂(Pls)减少,但其减少机制及其对神经炎症的影响仍不清楚。在本研究中,我们首次发现,各种炎性刺激通过激活核因子κB(NF-κB)降低了小鼠胶质细胞中的Pls水平,进而通过增加c-Myc在启动子上的募集,下调了一种Pls合成酶——甘油磷酸O-酰基转移酶(Gnpat)。我们还发现,全身注射脂多糖、衰老和慢性束缚应激会降低小鼠大脑皮层和海马体中的Pls含量,这与胶质细胞NF-κB激活、c-Myc表达增加以及Gnpat下调有关。更有趣的是,小鼠皮层中Pls含量的降低本身会增加小胶质细胞的激活表型和促炎细胞因子的表达,这表明大脑Pls减少会进一步加速神经炎症。在人类细胞系、三转基因AD小鼠大脑和AD患者尸检脑组织中也发现了类似的Pls减少机制。这些发现提示了一种新的神经炎症机制,这可能解释了AD的长期进展,并有助于我们探索治疗神经退行性疾病的预防和治疗策略。阿尔茨海默病(AD)患者大脑中的醚型甘油磷脂——缩醛磷脂(Pls)减少。我们发现,在小鼠和人类细胞系中,炎性刺激通过NF-κB介导的c-Myc募集到Gnpat启动子上,下调Pls合成酶甘油磷酸O-酰基转移酶(Gnpat),从而降低了Pls含量。全身注射脂多糖、慢性应激和衰老后的小鼠大脑,以及三转基因AD小鼠和AD患者尸检脑组织均显示c-Myc增加,Gnpat表达降低。有趣的是,在胶质细胞系和小鼠皮层小胶质细胞中敲低Gnpat本身会激活NF-κB。我们的发现为神经炎症机制提供了新的见解,并可能有助于开发针对AD等神经退行性疾病的新型治疗方法。